Daxor Corporation stock is up 0.12% since 30 days ago. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 25 February’s closed higher than January.
Daxor Corporation provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!